Novo Nordisk (NVO) Reports 10% Sales Growth as Obesity Care Hits DKK 82B
Novo Nordisk (NYSE:NVO) is one of the stocks that should double in 3 years. On February 4, Novo Nordisk delivered 10% sales growth in 2025, driven by its obesity and diabetes portfolios. The company’s obesity care sales reached DKK 82 billion, marking a substantial increase since 2019 and expanding its reach to 16 million additional patients. Financial results surpassed expectations with a reported EPS of $1, although the gross margin decreased to 81% due to manufacturing acquisitions and restructuring costs.
The year was highlighted by major regulatory and pipeline milestones, including the FDA approval and successful launch of the Wegovy pill, the first oral GLP-1 for weight management. Clinical data for CagriSema showed superior weight loss and glycemic control compared to semaglutide, and the company is progressing with its next-gen treatment, zenagamtide. Additionally, Novo Nordisk is expanding its focus into rare diseases and cardiovascular comorbidities, with several Phase III readouts and regulatory decisions anticipated throughout 2026.
Leadership transitions were also confirmed, with Jamey Millar and Hong Chow joining the executive team as several long-standing leaders depart. For 2026, Novo Nordisk (NYSE:NVO) issued a cautious financial outlook, projecting an adjusted sales and operating profit decline of 5% to 13% at constant exchange rates. This forecast accounts for significant pricing headwinds in the US and patent expirations in international markets, though the company remains focused on volume growth and long-term strategic aspirations to be unveiled at its upcoming Capital Markets Day.
Novo Nordisk (NYSE:NVO) together with its subsidiaries, engages in the R&D, manufacture, and distribution of pharmaceutical products. It has two segments: Obesity & Diabetes Care and Rare Disease.
While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Disclosure: None.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Beaver Creek: Mining’s next generation takes the wheel
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 12:51 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 12:51 PM
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Lower Oil Prices
09:12 AM EDT, 10/06/2026 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Tuesday's premarket activity amid lower oil prices and optimism around tech stocks. US stock futures were also higher, with S&P 500 Index futures up 0.5%, Dow Jones Industrial Average futures advancing 0.7%, and Nasdaq futures gaining 0.7% before the start of regular trading. The US international trade deficit widened to $105.57 billion in August from a $92.83 billion gap in July, compared with a $102.1 billion gap expected in a survey compiled by Bloomberg as of 7:35 am ET. In premarket activity, bitcoin was up by 0.7%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 1% higher, Ether ETF (EETH) advanced 1.6%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat. Power Play: Health Care The State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.3%, while the Vanguard Health Care Index Fund (VHT) and the iShares US Healthcare ETF (IYH) were inactive. The iShares Biotechnology ETF (IBB) was 0.7% higher. Option Care Health (OPCH) shares were up 21% pre-bell Tuesday after McKesson (MCK) and CD&R agreed to buy the company for roughly $5.80 billion. Winners and Losers: Technology The State Street Technology Select Sector SPDR ETF (XLK) gained 0.7%, the iShares US Technology ETF (IYW) was 0.5% higher, and the iShares Expanded Tech Sector ETF (IGM) was inactive. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was inactive, while the iShares Semiconductor ETF (SOXX) rose by 0.5%. Xanadu Quantum Technologies (XNDU) shares were up 7% in premarket activity after the company entered a multiyear deal with GlobalFoundries (GFS). GlobalFoundries was 1.4% higher. Financial The State Street Financial Select Sector SPDR ETF (XLF) advanced 0.3%. Direxion Daily Financial Bull 3X Shares (FAS) was up 0.9%, while its bearish counterpart, Direxion Daily Financial Be
Iran Tries to Oust Diplomat Who Met Trump Envoys: Will It Reverse Oil Price Slide?
Crypto prices
More
